Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney Sells 16,535 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) President Dawn Christine Maroney sold 16,535 shares of the firm's stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $16.40, for a total transaction of $271,174.00. Following the completion of the sale, the president now directly owns 2,374,051 shares in the company, valued at approximately $38,934,436.40. This trade represents a 0.69 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Dawn Christine Maroney also recently made the following trade(s):

• On Monday, March 17th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.99, for a total transaction of $479,700.00.
• On Wednesday, March 12th, Dawn Christine Maroney sold 27,243 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.43, for a total transaction of $420,359.49.
• On Thursday, March 6th, Dawn Christine Maroney sold 278,917 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.53, for a total transaction of $4,331,581.01.
• On Tuesday, February 18th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.72, for a total transaction of $411,600.00.
• On Wednesday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.61, for a total transaction of $408,300.00.

Alignment Healthcare Stock Performance

NASDAQ:ALHC traded up $0.43 during midday trading on Friday, reaching $17.61. The stock had a trading volume of 3,358,496 shares, compared to its average volume of 1,428,436. The firm has a fifty day simple moving average of $14.90 and a two-hundred day simple moving average of $12.73. Alignment Healthcare, Inc. has a 12-month low of $4.46 and a 12-month high of $17.76. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. The stock has a market cap of $3.38 billion, a P/E ratio of -22.87 and a beta of 1.49.

Remove Ads

Analysts Set New Price Targets

ALHC has been the topic of a number of research analyst reports. William Blair reissued an "outperform" rating on shares of Alignment Healthcare in a report on Friday, February 28th. JPMorgan Chase & Co. raised their price objective on shares of Alignment Healthcare from $14.00 to $17.00 and gave the stock a "neutral" rating in a report on Thursday, March 6th. Bank of America lifted their target price on shares of Alignment Healthcare from $15.50 to $18.50 and gave the company a "buy" rating in a report on Tuesday, March 4th. Barclays lifted their target price on shares of Alignment Healthcare from $8.00 to $9.00 and gave the company an "underweight" rating in a report on Friday, February 28th. Finally, Stifel Nicolaus lifted their target price on shares of Alignment Healthcare from $16.00 to $18.00 and gave the company a "buy" rating in a report on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $14.83.

Hedge Funds Weigh In On Alignment Healthcare

Hedge funds and other institutional investors have recently bought and sold shares of the company. R Squared Ltd purchased a new position in Alignment Healthcare in the 4th quarter valued at $55,000. RiverPark Advisors LLC purchased a new position in Alignment Healthcare in the 4th quarter valued at $106,000. Tower Research Capital LLC TRC grew its position in Alignment Healthcare by 146.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company's stock valued at $119,000 after buying an additional 6,286 shares during the last quarter. Ballentine Partners LLC purchased a new position in Alignment Healthcare in the 4th quarter valued at $121,000. Finally, Aigen Investment Management LP purchased a new stake in shares of Alignment Healthcare during the 4th quarter worth $129,000. 86.19% of the stock is currently owned by hedge funds and other institutional investors.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.